Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
83.44%Gross Margin
VS
Market
Sector
Industry
History
$ 57.77Close
$ 7.36 - $ 60.55 52-Week Range
Ticker Information
Ticker
NKTRCompany Name
NEKTAR THERAPEUTICSSector
HealthcareIndustry
BiotechnologyExchange
NASDAQNEKTAR THERAPEUTICS - Gross Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NKTR - Gross % Historical data
| Date | Gross Profit | Gross Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 62.52M | 83.44% | $ 74.93M |
| 3/31/2025 | $ 65.1M | 74.61% | $ 87.25M |
| 12/31/2024 | $ 67.74M | 68.82% | $ 98.43M |
| 9/30/2024 | $ 63.15M | 67.8% | $ 93.14M |
| 6/30/2024 | $ 55.17M | 59.22% | $ 93.16M |
| 3/31/2024 | $ 54.92M | 60.91% | $ 90.17M |
| 12/31/2023 | $ 56.35M | 62.53% | $ 90.12M |
| 9/30/2023 | $ 55.54M | 62.93% | $ 88.26M |
| 6/30/2023 | $ 62.48M | 71.21% | $ 87.74M |
| 3/31/2023 | $ 65.45M | 73.68% | $ 88.83M |
Key Performance Insights, Last 5 Years
- NEKTAR THERAPEUTICS's latest trailing twelve months (TTM) Gross % stands at 87.05%.
- Over the past 5 years, NEKTAR THERAPEUTICS's average Gross % has been 74.02%.
- The median Gross % for NEKTAR THERAPEUTICS during this period was 75.92%
- NEKTAR THERAPEUTICS reached its highest Gross % over the past 5 years at 87.26%.
- The lowest Gross % recorded by NEKTAR THERAPEUTICS in the same timeframe 59.22%
NEKTAR THERAPEUTICS's Gross % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Gross % Benchmarks
Similar metrics to Revenues:
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
Definition of Gross Margin
[Calculation] Gross margin, also called gross profit margin, represents the percentage of total revenue that the company retains after subtracting direct costs associated with producing the goods and services sold by the company [CoR]. Calculated by dividing gross profit [GP] by [Revenue].GP / Revenues
(=) Gross % Gross % for NEKTAR THERAPEUTICS is calculated as follows: GP [ $ 142.17M ] / Revenues [ $ 163.31M ]
(=) Gross % [ 87.05% ] NKTR - Gross Margin, Last 5 years
59.22%
Minimum
Jun 30, 2024
87.26%
Maximum
Dec 31, 2020
74.02%
Average
75.92%
Median
Gross % Benchmark AnalysisMarket
The chart above depicts the distribution of Gross % for companies in the Total Stock Market. The average Gross % of the companies is 53.09% with a standard deviation of 31.59%.
The following table provides additional summary stats:
Gross % in the Market:
| filtered constituents | 3.81K |
|---|---|
| min | -72.25% |
| max | 150.26% |
| average | 53.09% |
| median | 49.46% |
| std | 31.59% |